# Concept: Depreciation expense

## Bilingual Labels
- **EN**: Depreciation expense
- **KO**: 감가상각비

- **ID**: ifrs-full:DepreciationExpense

## Reported Numerical Facts

### **Context (Labels): Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]: Disclosed Amount [member] and Consolidated and separate financial statements [axis]: Consolidated [member]**
<!-- Context (IDs): ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis: dart:ReportedAmountMember and ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 18,775,772,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 20,173,061,000 (decimals: -3)

### **Context (Labels): Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]: Disclosed Amount [member] and Consolidated and separate financial statements [axis]: Separate [member]**
<!-- Context (IDs): ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis: dart:ReportedAmountMember and ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:SeparateMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 12,698,426,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 15,287,433,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 18,775,772,000 (decimals: 0)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 20,173,061,000 (decimals: 0)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 14,198,508,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 18,043,411,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 4,988,692,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 5,023,025,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:AllOtherSegmentsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: 56,788,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: 65,761,000 (decimals: -3)

### **Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]**
<!-- Context (IDs): ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis: ifrs-full:ConsolidatedMember and ifrs-full:SegmentConsolidationItemsAxis: ifrs-full:EliminationOfIntersegmentAmountsMember -->
- **Period: 2024-01-01 to 2024-03-31**
  - **Value**: -468,216,000 (decimals: -3)
- **Period: 2025-01-01 to 2025-03-31**
  - **Value**: -2,959,136,000 (decimals: -3)

## Accounting Standard References
- **Standard**: IAS 1.0, Paragraph: 112

---
*Source Document: entity00413046_2025-03-31.xbrl*
## Embeddable Text (for FAISS)
```text
Concept: Depreciation expense
Bilingual Labels
 EN: Depreciation expense
 KO: 감가상각비
 ID: ifrsfull:DepreciationExpense
Reported Numerical Facts
Context (Labels): Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]: Disclosed Amount [member] and Consolidated and separate financial statements [axis]: Consolidated [member]
<! Context (IDs): ifrsfull:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis: dart:ReportedAmountMember and ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember >
 Period: 20240101 to 20240331
   Value: 18,775,772,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 20,173,061,000 (decimals: 3)
Context (Labels): Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]: Disclosed Amount [member] and Consolidated and separate financial statements [axis]: Separate [member]
<! Context (IDs): ifrsfull:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis: dart:ReportedAmountMember and ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:SeparateMember >
 Period: 20240101 to 20240331
   Value: 12,698,426,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 15,287,433,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember >
 Period: 20240101 to 20240331
   Value: 18,775,772,000 (decimals: 0)
 Period: 20250101 to 20250331
   Value: 20,173,061,000 (decimals: 0)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 14,198,508,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 18,043,411,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: entity00413046:ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember >
 Period: 20240101 to 20240331
   Value: 4,988,692,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 5,023,025,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: All other segments [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:AllOtherSegmentsMember >
 Period: 20240101 to 20240331
   Value: 56,788,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 65,761,000 (decimals: 3)
Context (Labels): Consolidated and separate financial statements [axis]: Consolidated [member] and Segment consolidation items [axis]: Elimination of intersegment amounts [member]
<! Context (IDs): ifrsfull:ConsolidatedAndSeparateFinancialStatementsAxis: ifrsfull:ConsolidatedMember and ifrsfull:SegmentConsolidationItemsAxis: ifrsfull:EliminationOfIntersegmentAmountsMember >
 Period: 20240101 to 20240331
   Value: 468,216,000 (decimals: 3)
 Period: 20250101 to 20250331
   Value: 2,959,136,000 (decimals: 3)
Accounting Standard References
 Standard: IAS 1.0, Paragraph: 112
Source Document: entity00413046_20250331.xbrl
```